Resveratrol shows efficacy in 2 diabetes studies

09/20/2013 | NutraIngredients

Type 2 diabetes patients who received oral hypoglycemic agents and resveratrol supplements attained significant improvements in body weight, oxidative stress and lipid profile compared with those who received only oral hypoglycemic agents, according to a study in the International Research Journal of Pharmacy. Another study, published in the journal Evidence-Based Complementary and Alternative Medicine, showed short-term use of resveratrol fared better than placebo in curbing blood glucose and insulin levels in patients with type 2 diabetes.

View Full Article in:

NutraIngredients

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN